Area of research
Oncology · Cancer Research
Research interest
Research interests include Medicine, Internal medicine, Meta-analysis, Hazard ratio, Pancreatic cancer, and Cancer.
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization
Urinary Tumor DNA–based Liquid Biopsy in Bladder Cancer Management: A Systematic Review
Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination
Claudin 18.2: a promising actionable target in biliary tract cancers
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non‐Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)
Epstein-Barr Virus–Associated Gastric Cancer: A Histopathologic Study With Comprehensive Molecular Profiling
552 Epstein-Barr Virus Associated Gastric Cancer: a Histopathologic Study with Comprehensive Molecular Profiling
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Fusion genes in pancreatic tumors
Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer
Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to < 10%) Versus 2B (10% to ≤ 20%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols
DNA Methylation Profiling Enables Accurate Classification of Nonductal Primary Pancreatic Neoplasms
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer
Genetic and non-genetic risk factors for early-onset pancreatic cancer
Comprehensive characterisation of acinar cystic transformation of the pancreas: a systematic review
Differential Activity of MAPK signalling Defines Fibroblast Subtypes in Pancreatic Cancer
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)
MCL1 as putative target in pancreatoblastoma
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
Pathologic Examination of Pancreatic Specimens Resected for Treated Pancreatic Ductal Adenocarcinoma
Genome‐wide scan of long noncoding <scp>RNA</scp> single nucleotide polymorphism<scp>s</scp> and pancreatic cancer susceptibility
Molecular profiling of appendiceal serrated lesions, polyps and mucinous neoplasms: a single-centre experience
Genomic characterization of hepatoid tumors: context matters
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study